...
首页> 外文期刊>Medicine. >IgG4-Related Disease: Results From a Multicenter Spanish Registry
【24h】

IgG4-Related Disease: Results From a Multicenter Spanish Registry

机译:IgG4相关疾病:西班牙多中心注册表的结果

获取原文

摘要

IgG4-related disease (IgG4-RD) is a rare entity consisting of inflammation and fibrosis that has been described in multiple organs. Concrete diagnostic criteria have been established recently and there is a lack of large series of patients. To describe the clinical presentation, histopathological characteristics, treatment and evolution of a series of IgG4-RD Spanish patients. A retrospective multicenter study was performed. Twelve hospitals across Spain included patients meeting the current 2012 consensus criteria on IgG4-RD diagnosis. Fifty-five patients were included in the study, 38 of whom (69.1%) were male. Median age at diagnosis was 53 years. Thirty (54.5%) patients were included in the Histologically Highly Suggestive IgG4-RD group and 25 (45.5%) in the probable IgG4-RD group. Twenty-six (47.3%) patients had more than 1 organ affected at presentation. The most frequently affected organs were: retroperitoneum, orbital pseudotumor, pancreas, salivary and lachrymal glands, and maxillary sinuses. Corticosteroids were the mainstay of treatment (46 patients, 83.6%). Eighteen patients (32.7%) required additional immunosuppressive agents. Twenty-four (43.6%) patients achieved a complete response and 26 (43.7%) presented a partial response (<50% of regression) after 22 months of follow-up. No deaths were attributed directly to IgG4-RD and malignancy was infrequent. This is the largest IgG4-RD series reported in Europe. Patients were middle-aged males, with histologically probable IgG4-RD. The systemic form of the disease was frequent, involving mainly sites of the head and abdomen. Corticosteroids were an effective first line treatment, sometimes combined with immunosuppressive agents. Neither fatalities nor malignancies were attributed to IgG4-RD.
机译:IgG4相关疾病(IgG4-RD)是由多种器官中描述的由炎症和纤维化组成的罕见实体。最近已经建立了具体的诊断标准,并且缺乏大量的患者。为了描述一系列IgG4-RD西班牙患者的临床表现,组织病理学特征,治疗和演变。进行了一项回顾性多中心研究。西班牙的12家医院纳入了符合2012年有关IgG4-RD诊断的共识标准的患者。该研究纳入了55名患者,其中38名(69.1%)是男性。诊断时的中位年龄为53岁。在组织学上高度提示的IgG4-RD组中包括30名(54.5%)患者,在可能的IgG4-RD组中包括25(45.5%)。二十六名患者(47.3%)在报告时受到了超过1个器官的影响。受影响最严重的器官是:腹膜后,眶假瘤,胰腺,唾液和泪腺以及上颌窦。皮质类固醇是治疗的主体(46例患者,占83.6%)。 18名患者(32.7%)需要其他免疫抑制剂。随访22个月后,二十四名患者(43.6%)达到了完全缓解,而26名患者(43.7%)出现了部分缓解(<消退的50%)。没有死亡直接归因于IgG4-RD,恶性肿瘤很少见。这是欧洲报道的最大的IgG4-RD系列。患者是中年男性,具有组织学上可能的IgG4-RD。该疾病的系统性形式很常见,主要涉及头和腹部的部位。皮质类固醇是有效的一线治疗,有时与免疫抑制剂联用。死亡或恶性肿瘤均不归因于IgG4-RD。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号